4//SEC Filing
Menzaghi Frederique Ph.D. 4
Accession 0001209191-21-018656
CIK 0001346830other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:48 PM ET
Size
7.2 KB
Accession
0001209191-21-018656
Insider Transaction Report
Form 4
Menzaghi Frederique Ph.D.
VP-Research & Development
Transactions
- Award
Common Stock
2021-03-04+10,000→ 122,677 total - Sale
Common Stock
2021-03-05$17.98/sh−3,358$60,377→ 119,319 total
Footnotes (2)
- [F1]Represents the number of shares that vested under a performance-based restricted stock unit award (the "RSU") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which occurred on March 4, 2021. Each RSU represents the contingent right to receive one share of common stock of the Issuer.
- [F2]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001597152
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 5:48 PM ET
- Size
- 7.2 KB